Standout Papers
Immediate Impact
1 by Nobel laureates 1 from Science/Nature 63 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Alan Nicholas being referenced
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
2021 Standout
Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3).
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alan Nicholas | 660 | 180 | 412 | 708 | 23 | 1.4k | |
| Leonid Dubrovsky | 812 | 128 | 268 | 831 | 29 | 1.5k | |
| John A. Conti | 1075 | 118 | 296 | 659 | 24 | 1.5k | |
| Jessica Spahn | 484 | 135 | 252 | 421 | 25 | 1.1k | |
| Florian Castet | 492 | 313 | 356 | 448 | 18 | 1.3k | |
| Laia Bassaganyas | 403 | 312 | 300 | 409 | 21 | 1.1k | |
| Giovanni Benedetti | 1043 | 149 | 356 | 439 | 20 | 1.4k | |
| Domenico Magazzù | 882 | 554 | 207 | 111 | 18 | 1.3k | |
| Stella Y. Tsai | 458 | 316 | 363 | 314 | 24 | 1.3k | |
| Robert Königsberg | 660 | 354 | 162 | 347 | 31 | 1.4k | |
| Henry Xiong | 758 | 217 | 297 | 155 | 20 | 1.1k |
All Works
Loading papers...